Why the study?
Do extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction?
Do extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction?
Extracellular vesicles from human cardiac progenitor cells offer a potential cell-free approach to improve cardiac function and inhibit apoptosis after myocardial infarction.
Supports preclinical EV therapy exploration post-MI; leaves open human translation and trials.
EVs are the active component of the paracrine secretion by human CPCs. As a cell-free approach, EVs could circumvent many of the limitations of cell transplantation.
No takes yet. Share an insight, caveat, or question.
Barile et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: